AllSides Balanced Search reveals information and ideas from all sides of the political spectrum so you can get the full picture.
Oct 11 2021
News
Merck asks FDA for emergency approval of its antiviral COVID-19 pill
Pharmaceutical giant Merck and its partner Ridgeback Biotherapeutics announced Monday that it has asked the Food and Drug Administration for emergency approval of its COVID-19 pill after the experimental drug showed “compelling results” in clinical trials.
The pill, called molnupiravir, cut the risk of hospitalization or death in patients with mild to moderate COVID-19 by about 50
New York Post (News)Aug 14 2017
News
Merck CEO pulls out of Trump panel, demands rejection of bigotry
Merck's chief executive resigned on Monday from a business panel led by Donald Trump, citing a need for leadership countering bigotry in a strong rebuke to the U.S. president over his response to a violent white nationalist rally in Virginia.
ReutersAug 14 2017
News
Merck CEO resigns from presidential council over Trump remarks
An African-American CEO of a major pharmaceutical company has resigned from a presidential council in a direct response to President Trump's remarks about "many sides" being to blame for violence over the weekend in Charlottesville, Va.
The HillOct 11 2021
News
What we know — and don’t know — about Merck’s new Covid-19 pill
The announcement that a pill from Merck and partner Ridgeback Biotherapeutics kept Covid patients out of the hospital made headlines and moved stocks late last week. But as is so often true when data are released by press release, there are still many questions left unanswered.
Doctors are excited about the medicine, molnupiravir, because a regimen of pills, even one that involves
STATOct 01 2021
News
Merck's promising experimental Covid-19 drug raises hopes for pill to fight virus
News that an experimental antiviral drug from Merck appears to halve the risk of hospitalization or death from Covid-19 has bolstered hopes of finding a simple at-home treatment for the virus.
The drug, molnupiravir, is given as a pill. It performed well enough in a late-stage clinical trial of adults at high risk of severe Covid-19 that the independent review board overseeing the study
PoliticoApr 04 2024
News
North Penn To Hold Special Programming During Eclipse For Students
LANSDALE, PA — The North Penn School District has announced special programming for the upcoming eclipse on April 8, in which the moon will cover about 90 percent of the sun as it crosses its face. Merck West Point has donated more than 14,000 pairs of eclipse glasses for the entire school district to watch the event. "This is a rare and exciting astronomical event that presents a unique
Patch.comDec 06 2021
News
Pfizer and Merck Covid-19 Pills Are Coming Soon in the U.S., but Other Countries Will Have to Wait
Promising Covid-19 treatment pills are likely to take longer to reach patients in low- and middle-income countries than in rich ones because of manufacturing and pricing obstacles, despite efforts by drugmakers to make them more available, drug-access advocates and public-health experts say.
The pills promise to keep people who get infected from developing severe disease that requires
Wall Street Journal (News)Nov 04 2021
News
Britain authorizes Merck’s molnupiravir, the world’s first approval of oral covid-19 treatment pill
Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck on Thursday, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.
Experts have said that if widely authorized, the medicine could have huge potential to help fight the coronavirus pandemic: Pills are easier to take
Washington PostJun 17 2021
News
US Spending $1.2 Billion on Merck’s COVID-19 Treatment Is a ‘Waste of Taxpayers’ Money’: Doctor
A critical care doctor has said it’s a waste of taxpayers’ money for the U.S. government to purchase drug company Merck’s anti-viral treatment for COVID-19, if it’s approved by the Food and Drug Administration (FDA).
Dr. Pierre Kory, president and chief medical officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), said there’s no reason for the Biden administration to “
The Epoch TimesAug 14 2017
News
Trump fires back after the CEO of Merck resigned from his manufacturing council
The chief executive of Merck said Monday in a tweet that he was resigning from President Trump's American Manufacturing Council, saying he was doing so “as CEO of Merck and as a matter of personal conscience” and that “America's leaders must honor our fundamental values by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all
Washington Post